Market & Product Diligence
Every product is evaluated against the real U.S. landscape — competition, pricing, channel dynamics, and regulatory pathway — before a deal is proposed.
Services
Two sides of every deal. One trusted partner.
GPP sits at the center of a two-sided network: global R&D companies with excellent products, and U.S. pharmaceutical businesses ready to commercialize them. Our services are built for both.
For Global R&D Companies
Your pathway into the U.S. and Canada.
You've built the dossier. We open the market — and stay with you through launch and beyond.
- Dossier evaluation and U.S. commercial opportunity assessment
- Licensing and acquisition of high-value pharmaceutical developments
- Placement with world-class U.S. pharmaceutical customers from our established network
- Deal structuring, negotiation, and agreement execution
- Development costs covered under our standard deal terms — typically shared 50/50 with the U.S. partner
- Long-term portfolio expansion across generics, specialty, 505(b)(2), devices, and biologicals
For U.S. Pharmaceutical Businesses
A curated pipeline of global products.
Skip the search. GPP brings you vetted, high-value products from top global R&D companies — matched to your channels and capabilities.
- Access to a continuously refreshed portfolio of global dossiers
- Products screened for quality, supply reliability, and commercial fit
- Introductions to proven R&D partners across 89 countries
- Support through diligence, registration, and launch
- Deal terms structured for durable, profitable partnerships
- A pipeline that grows with you — from generics to biologicals
How We Work
What every engagement includes.
Trusted Intermediation
GPP has spent two decades earning the trust of both sides. Confidentiality, fair dealing, and follow-through are how we've grown year after year.
Deal Structuring & Execution
From term sheet to signature, GPP structures agreements that hold up — for the developer, the commercial partner, and the long life of the product.
Lifecycle Partnership
We don't disappear at signing. GPP supports registration, launch, and growth — expanding partner portfolios with the next product, and the next.
Capabilities
A full-service network behind every deal.
Beyond licensing, GPP connects partners to the full range of capabilities a product needs to reach the U.S. and Canadian markets — including deep experience in 505(b)(2) regulatory pathways that build on established molecules for faster, differentiated approvals.
Regulatory
FDA and Health Canada strategy, submissions, and lifecycle compliance — including 505(b)(2) pathways.
Clinical Research Organizations
CRO selection and oversight for studies that support U.S. registration.
Legal, Patents & Paragraph IV
IP strategy, patent review, and Paragraph IV certification support.
Contract Manufacturing
CMO/CDMO sourcing and tech transfer for reliable, compliant supply.
API Sourcing
Qualified API suppliers with the quality and documentation U.S. partners require.
Business Development
Deal origination and partner matchmaking across our global network.
Market Analysis
Competitive, pricing, and opportunity assessment for the U.S. and Canada.
Portfolio Management
Building and expanding product portfolios across the development spectrum.
Contract Negotiations
Structuring and negotiating licensing and acquisition agreements.
Sales & Marketing
Commercialization support through launch and ongoing growth.
Start Here
Get in Touch
Which side of the deal are you on?
Either way, the next step is the same — a conversation with GPP.